Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Oct 2026 for PTC Therapeutics, INC., €11k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Boulding Mark Elliott: trading record in brief
Boulding Mark Elliott appears in our data through filings on PTC Therapeutics, Inc. shares, published by SEC (Form 4). In total, 6 filings cover trades dated from 17 June 2026 to 9 October 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 9 October 2026, the filings show a transaction worth €11k in PTC Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Boulding Mark Elliott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
192 shares@ US$64.2648CommonSEC144:0001959173-26-007327
435 shares@ US$64.15540.0005% mcap0.3% of flowCommonSEC144:0001959173-26-007297
1,638 shares@ US$64.03140.0020% mcap1.1% of flowCommonSEC144:0001959173-26-007274
2,813 shares@ US$71.700.0038% mcap2.1% of flowCommonSEC144:0001959173-26-006063
5,079 shares@ US$84.1350.0081% mcap4.6% of flowCommonSEC144:0001959173-26-005114
10,522 shares@ US$78.65490.012% mcap8.8% of flowCommonSEC144:0001959173-26-004755
6 of 6 declarations
